Lacrimer ™ Patient Customized Eye Drops

Autologous PRP Eye Drops

What are Autologous PRP Eye Drops?

Autologous Platelet Rich Plasma (PRP) is concentrated platelets and white blood cells produced through centrifugation of the patient’s own blood. At the time of the procedure, a small volume of blood is drawn from the patient via venipuncture. The blood sample is then concentrated via centrifugation. Upon concentration, the platelets are removed and prepared for eye drops.

In our experience, we have found that patients who have been unable to obtain relief through other methods may have success with this treatment. The treatment is very safe and effective for the treatment of chronic and symptomatic Dry Eye Syndrome. Other indications for the use of Autologous PRP Eye Drops may include Ulcers and Ocular Surface Syndrome Post LASIK.

Benefits of Autologous PRP Drops

  • Accelerated and enhanced healing
  • Reduced inflammation
  • Symptomatic improvement of Dry Eye Syndrome
  • Effective in treating ulcers
  • Reduction in pain
  • May restore the corneal epithelial surface in patients with corneal ulcers

The known contraindications for Autologous PRP eye drops:

  • Platelet Dysfunction Syndrome
  • Critical Thrombocytopenia
  • Hypofibrinogenemia
  • Ongoing Dry Eye Infection

Please notify your physician if you have any of the known contraindications listed above.

Costs: At this time, Autologous PRP Eye Drops are NOT covered by insurance companies. Therefore, it is an out-of-pocket expense to the patient.

If you are a physician or clinic interested in learning the LACRIMER preparation of Autologous PRP Eye Drops, we are available as a consultant for a fee. Please contact our office at 706-258-7770.

PRP In The Literature

The clinical use of PRP has been studied in many medical specialties, including Orthopedics, Plastics, ENT, OB/GYN, Ophthalmology, Oral, and General surgery. For more information, we have referenced the following literature:

Alio J, Colecha J, et al. Symptomatic Dry Eye Treatment with Autologous Platelet-Rich Plasma. Ophthalmic Res 2007; 39: 124-129.

Alio J, Pastor S, et al. Treatment of Ocular Surface Syndrome after LASIK with Autologous Platelet-rich Plasma. Journal of Refractive Surgery 2007; 23: 617-619. 

Alio J, Abad M, et al. Use of Autologous Platelet-Rich Plasma in the Treatment of Dormant Corneal Ulcers. Ophthalmology 2007; 114: 1286-1293.

Koffler B. Autologous Serum Therapy of the Ocular Surface with Novel Delivery by Platelet Concentrate Gel. The Ocular Surface 2006; 4(4): 188-195. 

Marquez-de-Arecena R, Montero-de-Espinosa I, et al. Subconjunctival Application of Platelet Rich Plasma Concentrate in the Treatment of Ocular Burns: Preliminary Results. Arch Soc Esp Oftalmol 2007; 82: 475-482.